top of page

NCI-2020-07076

A Phase 1 Study of SRF388 in Patients with Advanced Solid Tumors


This study aims to examine the safety and effectiveness of SRF388, a new drug, in treating patients with advanced solid tumors. People with advanced or metastatic solid tumors can participate.

metastatic: cancer that has spread from its original location or organ to other parts of the body.

For more information about the trial, click the link below:

Clinical Trial Site: Sinai


To see all available clinical trials click here.



Recent Posts

See All

NCI-2023-00614

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator's Choice of...

NCI-2021-00222

NRG-BR007: A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone...

NCT01042379

I-SPY TRIAL: Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2. This research...

Comments

bottom of page